Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Lotus Eye Hospital and Institute Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Lotus Eye Hospital and Institute has a total shareholder equity of ₹594.1M and total debt of ₹11.1M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are ₹666.3M and ₹72.2M respectively. Lotus Eye Hospital and Institute's EBIT is ₹22.0M making its interest coverage ratio -6.1. It has cash and short-term investments of ₹69.3M.
Anahtar bilgiler
1.9%
Borç/özkaynak oranı
₹11.10m
Borç
| Faiz karşılama oranı | -6.1x |
| Nakit | ₹69.30m |
| Eşitlik | ₹594.09m |
| Toplam yükümlülükler | ₹72.18m |
| Toplam varlıklar | ₹666.27m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: LOTUSEYE's short term assets (₹140.2M) exceed its short term liabilities (₹62.3M).
Uzun Vadeli Yükümlülükler: LOTUSEYE's short term assets (₹140.2M) exceed its long term liabilities (₹9.9M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: LOTUSEYE has more cash than its total debt.
Borcun Azaltılması: LOTUSEYE's debt to equity ratio has increased from 0.2% to 1.9% over the past 5 years.
Borç Kapsamı: LOTUSEYE's debt is well covered by operating cash flow (511.8%).
Faiz Kapsamı: LOTUSEYE earns more interest than it pays, so coverage of interest payments is not a concern.